← Leaderboards
Harinder S. Juneja
University Of Texas Hlth Sci Ctr Houston
$26,242
Attributed
$26,242
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$26,242 · 3
By mechanism
M01$26,242 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Jessica Cardenas$1,641,301
- Gailen D. Marshall$6,643,602
- Bharti Manwani$3,508,353
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman Therapy EvaluationHuman SubjectSickle Cell AnemiaDrug Screening /EvaluationBlood Disorder ChemotherapyPharmacokineticsMedical ComplicationAcute Disease /DisorderAnalgesicsAntithrombinsBlood ViscosityCopolymerCoronary Occlusion /ThrombosisDrug Administration Rate /DurationHospital UtilizationLongitudinal Human StudyPainPlacebosPolyethylene GlycolsSickle Cell CrisisBlood Cell CountTestosteroneCombination Chemotherapy
Grant awards (7)
FLOCOR IN PATIENTS W/ SICKLE CELL DISEASE IN ACUTE VASO OCCLUSIVE CRISIS$0
M01 · FY2002 · RR
FLOCOR in patients with sickle cell disease in vasoocculsive crisis$0
M01 · FY2002 · RR
FLOCOR IN PATIENTS W/ SICKLE CELL DISEASE IN ACUTE VASO OCCLUSIVE CRISIS$0
M01 · FY2001 · RR
FLOCOR in patients with sickle cell disease in vasoocculsive crisis$0
M01 · FY2001 · RR
ANDROSTANE THERAPY OF APLASTIC ANEMIA WITH 3-ETIOCHOLANOLONE &TESTOSTERONE$15,114
M01 · FY2000 · RR
FLOCOR IN PATIENTS W/ SICKLE CELL DISEASE IN ACUTE VASO OCCLUSIVE CRISIS$11,128
M01 · FY2000 · RR
FLOCOR in patients with sickle cell disease in vasoocculsive crisis$0
M01 · FY2000 · RR